Insulet CEO Ashley McEvoy Buys $160,000 in Shares Amid Stock Decline
Ashley McEvoy, the President and CEO of Insulet Corporation (NASDAQ:PODD), purchased $162,217 worth of shares on August 21, 2026. The open-market transaction involved buying 1,100 shares at a weighted average price of $147.47 across multiple trades ranging from $147.42 to $147.62. This purchase increases McEvoy's direct ownership stake in the company to 23,731 shares and adds to her total equity position valued at approximately $3.52 million as of August 21 market close ($148.16 per share). The move comes after a significant decline in Insulet’s stock price—down over 55% from its peak—and has drawn attention for what it may signal about the company's future prospects. Insulet, which develops and sells insulin delivery systems like the Omnipod platform, reported trailing twelve-month revenue of $3.1 billion and net income of $375.3 million as of the latest reporting period. The CEO’s purchase is seen by some investors as a vote of confidence in the company's long-term value.
Tickers: $PODD